These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 17592282)

  • 1. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors.
    Sauvanet A; Mariette C; Thomas P; Lozac'h P; Segol P; Tiret E; Delpero JR; Collet D; Leborgne J; Pradère B; Bourgeon A; Triboulet JP
    J Am Coll Surg; 2005 Aug; 201(2):253-62. PubMed ID: 16038824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
    BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.
    Barbour AP; Rizk NP; Gerdes H; Bains MS; Rusch VW; Brennan MF; Coit DG
    J Am Coll Surg; 2007 Oct; 205(4):593-601. PubMed ID: 17903735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Margins of resection of the esophagus for gastric cancer with esophageal invasion.
    Tsujitani S; Okuyama T; Orita H; Kakeji Y; Maehara Y; Sugimachi K; Kaibara N
    Hepatogastroenterology; 1995; 42(6):873-7. PubMed ID: 8847038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
    Ti TK
    Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Whole laparoacopic trans-hiatal extended total gastrectomy with the Or-Vil device: preliminary results in the treatment of Siewert type II and III tumors].
    Siani LM; Ferranti F; Marzano M; Benedetti M; Quintiliani A
    Chir Ital; 2009; 61(3):289-94. PubMed ID: 19694230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extent of radical surgery in cardia carcinoma--esophagectomy or gastrectomy?].
    Hölscher AH; Bollschweiler E; Beckurts KT; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():169-72. PubMed ID: 9101821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer.
    Markar SR; Gronnier C; Duhamel A; Pasquer A; Théreaux J; Chalret du Rieu M; Lefevre JH; Turner K; Luc G; Mariette C;
    Ann Surg; 2016 Apr; 263(4):712-8. PubMed ID: 26135681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of adenocarcinoma of the gastroesophageal junction.
    Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.